Moderna cuts sales forecasts for its COVID-19 vaccine

Bio Pharma Dive

The biotech dialed back its financial projections after reporting lower-than-expected sales for the shot, which currently remains the company’s only marketed product

Sales 246

Bristol Myers CAR-T sales rise, despite production problems

Bio Pharma Dive

A manufacturing issue for Breyanzi, meanwhile, impacted sales Demand has increased faster than Bristol Myers can make Abecma, although the company said supply is improving.

Sales 241
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

Pharma earnings outline drug law’s looming impact on sales, development

Bio Pharma Dive

While many companies are still unsure of the Inflation Reduction Act's effects, some have begun to warn investors about the likelihood of lower sales and reduced profitability

Sales 259

Aerie’s glaucoma drug journey ends in $770M sale to Alcon

Bio Pharma Dive

The biotech successfully brought two medicines to market, but shares have lost most of their value amid sluggish sales

Sales 235

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

Novo obesity drug sales lag as manufacturing problems persist

Bio Pharma Dive

Manufacturing problems continue to weigh on Novo’s Wegovy launch as competition looms from Eli Lilly’s fast-selling diabetes medicine Mounjaro

Sales 246

Novartis sales of Zolgensma gene therapy slow as market shifts

Bio Pharma Dive

Treatment is now mostly of infants newly diagnosed with spinal muscular atrophy, as many of those previously eligible either already received Zolgensma or other drugs from Biogen and Roche

US plans shift to private market sales of COVID-19 vaccines, drugs

Bio Pharma Dive

The federal government will begin the transition as early as this fall, clearing the way for drugmakers to control sales and distribution of their shots and therapeutics

Sales 227

J&J predicts faster coronavirus vaccine sales amid debate over boosters

Bio Pharma Dive

billion in sales from its shot this year, despite concerns over protection against variants and significant manufacturing setbacks The pharmaceutical company expects $2.5

Sales 246

Sales manager

Pharma Phorum

Create and disseminate sales support materials. Manage and develop sales team (sales manager role only). Proven experience of working as part of a sales team. Proven work experience working in a sales-based role. The post Sales manager appeared first on.

Sales 83

Gilead sales propped up by COVID-19 drug Veklury

Bio Pharma Dive

Sales of the antiviral drug accounted for a quarter of the biotech's product revenue in the fourth quarter, disguising hits to its business elsewhere

Sales 246

AbbVie cancer drug sales fall as AstraZeneca competitor gains ground

Bio Pharma Dive

Imbruvica, long one of AbbVie’s top-selling medicines, has ceded market share in treating chronic lymphocytic leukemia to AstraZeneca’s Calquence

Sales 235

Novartis wins FDA approval for new heart drug, but faces uphill sales battle

Bio Pharma Dive

Leqvio, which Novartis acquired for nearly $10 billion two years ago, arrives with high sales expectations. But uptake could be slow as insurers and doctors weigh the drug's safety and cost-effectiveness

Gilead, fueled by latest approval, sees CAR-T sales take off

Bio Pharma Dive

After a slow start, Gilead’s CAR-T business is growing fast, enabling it to pull ahead of rival cell therapy developers like Bristol Myers Squibb and Johnson & Johnson

Sales 272

Moderna vaccine sales surpass expectations as company looks to fall boosters

Bio Pharma Dive

The trajectory of COVID-19 vaccine sales is now harder to predict amid questions about the rollout of additional doses and whether purchasing in the U.S.

Sales 227

Novartis said to be eyeing sale of ophthalmology, respiratory units

Pharma Phorum

Novartis has already spun out its eyecare business Alcon, and is now considering the sale of its ophthalmology and respiratory medicines businesses as it continues a narrowing of its focus, according to media reports.

Sales 100

Yumanity cutting 60% of employees as it mulls possible sale

Bio Pharma Dive

The layoffs — which, according to Yumanity, should be completed by April — are part of a larger restructuring effort meant to reduce costs after a recent setback to the company's most advanced drug program

Sales 263

Merck, GSK vaccine sales hit by pandemic as competitors' business booms

Bio Pharma Dive

Both companies blamed the impact of COVID-19 on sharp declines in sales of their shingles, pneumonia and HPV shots

Sales 250

Lilly sales of new diabetes drug accelerate on rising patient demand

Bio Pharma Dive

Company executives highlighted the “viral nature” of demand for Mounjaro, which was approved in May for diabetes and has also shown a strong weight-loss benefit in clinical testing

Sales 246

Esperion lays off nearly half its workforce as heart drug sales disappoint

Bio Pharma Dive

The company hopes a "streamlined" sales force can turn around a drug launch that's failed to meet expectations amid tough competition from rival medicines

Sales 235

Merck sees up to $7B in coming sales of coronavirus pill

Bio Pharma Dive

But sales could climb even higher if it works as a preventive treatment too Executives based their projections on contracts already in place for the drug, known as molnupiravir.

Sales 253

Biogen's Alzheimer's drug sales remain slow as company warns of further cost cuts

Bio Pharma Dive

Aduhelm sales totaled just $1 million in the fourth quarter as Biogen struggles to win over doctors and insurers. The company said it would reduce expenses by more than currently planned if Medicare limits coverage

Sales 227

After setbacks, a gene therapy company mulls a sale

Bio Pharma Dive

Sio Gene Therapies, formerly known as Axovant, said it's focused on conserving cash, and has decided to significantly reduce its workforce and terminate licensing agreements on its last two pipeline programs

Pfizer forecasts $15B sales boost from coronavirus vaccine orders

Bio Pharma Dive

The estimate for 2021 sales, which Pfizer splits with partner BioNTech, would make the vaccine one of the highest-selling medicines in the industry

Sales 192

Seagen shares sink as sales outlook of cancer drug disappoint

Bio Pharma Dive

The biotech is predicting sales of Tukysa, its new breast cancer drug, will remain flat or fall in 2022 as competition increases from AstraZeneca's rival medicine Enhertu

Sales 157

Pfizer forecasts $100B in sales, fueled by COVID-19 vaccine, pill

Bio Pharma Dive

The company estimated revenue from its COVID-19 vaccine and antiviral pill Paxlovid will total $54 billion this year. Curiously, its stock fell by more than 5

Sales 241

Career Advancement Tips for Pharmaceutical Sales

BioSpace

Find out what it takes to become a successful pharma sales rep and discover helpful career advancement tips for pharmaceutical sales professionals

Sales 87

Vaccine sales driven down by pandemic's effects on doctor visits

Bio Pharma Dive

Pfizer, Sanofi, GSK and Merck each reported lower vaccine sales as stay-at-home orders kept people from their regular vaccinations

Pfizer sales of COVID-19 vaccine climb, with tens of billions more expected next year

Bio Pharma Dive

The drugmaker again increased its forecast for 2021 sales, this time to $36 billion, or about 80% of what the rest of Pfizer's business is expected to earn this year

Sales 227

Argenx drug succeeds in trial, beats sales forecasts

Bio Pharma Dive

The biotech reported positive results from a study meant to expand Vyvgart's use to another immune disorder, while sales from the drug's first quarter on the market exceeded expectations

Sales 130

Why Uncrustables Sales Skyrocketed in 2022

XTalks

Despite higher input costs and supply chain struggles, the company saw quarterly sales growth fueled by the market strength of its beloved crustless peanut butter and jelly sandwiches. Total company net sales of Uncrustables sandwiches were $168 million this quarter.”.

Sales 82

Securing Sales Solutions in Pharma

Pharmaceutical Commerce

Contract sales organizations are evolving alongside the companies they serve.

Sales 52

Biohaven beats expectations with fast sales of migraine drug

Bio Pharma Dive

Second quarter sales of Nurtec ODT, which recently became the first migraine drug cleared for acute and preventive treatment, were nearly twice what analysts on Wall Street had predicted

Sales 163

Pfizer sales of COVID-19 vaccine, pill beat forecasts as company prepares for future waves

Bio Pharma Dive

The company plans to ready a booster shot by the fall that targets the BA.4 and BA.5 strains that are currently most prevalent in the U.S. and other countries

Sales 253

Agios CEO to step down, handing role to veteran in rare disease drug sales

Bio Pharma Dive

A former Celgene executive, Jackie Fouse has led Agios since 2019, overseeing its transformation into a company focused solely on uncommon diseases. In August, she will transition to chair its board of directors

Sales 256

Eversana aims athletes’ mental coaching at pharma sales reps

Pharma Phorum

Eversana’s suite of commercialisation tools for pharma companies will soon have a new component – cognitive behavioural training tools designed to improve the performance of sales representatives. Digital News Sales and Marketing digital Sales reps Training

Sales 95

Gilead, following cell therapy approval, impresses Wall Street with fast sales

Bio Pharma Dive

Together, the biotech’s two CAR-T therapies earned $368 million between April and June, a substantial jump over last year and above what analysts forecast

Sales 235

Amgen expects rising sales through 2030, but Wall Street still has doubts

Bio Pharma Dive

Facing falling sales of top-seller Enbrel, the biotech tried to shore up confidence in its ability to grow new products, like the cancer drug Lumakras

Sales 157

Sales coaching: preparing for the new reality in pharma

Pharma Phorum

COVID-19 has been a catalyst for a huge amount of change across the pharmaceutical industry, acting as an accelerant for progress in its use of digital technology and prompting a reassessment of how the sales function should work. The industry faces the dawn of a new age in sales coaching.

Sales 81

Rebranded Servier eyes €3bn in cancer drug sales by 2030

Pharma Phorum

Servier is already in the process of transforming itself into a much bigger player in cancer, and has just tripled its sales objectives for the category. ” Its updated plan predicts group sales of €6 billion in 2025 and operating profits of around €1.3

Sales 83

Artificial Intelligence (AI) in Pharma Sales and Marketing

Pharma Mirror

The post Artificial Intelligence (AI) in Pharma Sales and Marketing appeared first on Pharma Mirror Magazine. Pharmaceutical Articles artificial intelligence Pharma Sales and MarketingWhat is AI?

Sales 52

Novartis expects sales lift from expanded heart drug approval

Bio Pharma Dive

The Swiss drugmaker's pill Entresto is now cleared in the U.S. for use in patients with stronger hearts, expanding the eligible population by two-thirds

Sales 230

Biogen and its partner rework terms of Aduhelm deal amid slow sales

Bio Pharma Dive

Instead of sharing global profits and losses, Eisai will receive royalties tied to net sales of the Alzheimer's drug. Biogen, meanwhile, said the amended deal should make it easier to "address market developments "

Sales 149